D.A. Davidson & Co. »

Outlook Therapeutics shares owned by D.A. Davidson & Co.

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by D.A. Davidson & Co. from 13F filings

Historical chart of D.A. Davidson & Co. investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by D.A. Davidson & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by D.A. Davidson & Co.

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 28k 0.39
2023-09-30 $6.2k 28k 0.22

More positions owned by D.A. Davidson & Co.

Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 2000 Val Etf (IWN)
Spdr Ser Tr Portfolio Intrmd (SPIB)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Rus 2000 Grw Etf (IWO)
Costco Wholesale Corporation (COST)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for D.A. Davidson & Co.

Top funds holding Outlook Therapeutics

Vanguard Group
Charles Schwab Investment Management
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
Gables Capital Management
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors

View all funds holding Outlook Therapeutics